BACKGROUND: Myeloperoxidase (MPO) colocalizes with macrophages in the human artery wall, and its characteristic oxidation products have been detected in atherosclerotic lesions. Thus, oxidants produced by the enzyme might promote atherosclerosis. However, macrophages in mouse atherosclerotic tissue do not express MPO. Therefore, mice are an inappropriate model for testing the role of MPO in vascular disease. To overcome this problem, we generated and studied transgenic (Tg) mice that contained the human MPO gene. METHODS AND RESULTS: We produced human MPO-Tg mice with use of a Visna virus promoter. To confine MPO expression to macrophages, we lethally irradiated LDL receptor-deficient mice and repopulated their bone marrow with cells from wild-type mice or MPO-Tg mice. Despite having similarly high levels of cholesterol after maintenance on a high-fat, high-cholesterol diet, the MPO-Tg animals developed a 2-fold greater atherosclerotic area in the aorta than did mice transplanted with wild-type bone marrow (P=0.00003). CONCLUSIONS: Our observations indicate that expression of human MPO in macrophages promotes atherosclerosis in hypercholesterolemic mice, raising the possibility that the enzyme might be a potential therapeutic target for preventing cardiovascular disease in humans.
BACKGROUND:Myeloperoxidase (MPO) colocalizes with macrophages in the human artery wall, and its characteristic oxidation products have been detected in atherosclerotic lesions. Thus, oxidants produced by the enzyme might promote atherosclerosis. However, macrophages in mouseatherosclerotic tissue do not express MPO. Therefore, mice are an inappropriate model for testing the role of MPO in vascular disease. To overcome this problem, we generated and studied transgenic (Tg) mice that contained the humanMPO gene. METHODS AND RESULTS: We produced humanMPO-Tg mice with use of a Visna virus promoter. To confine MPO expression to macrophages, we lethally irradiated LDL receptor-deficient mice and repopulated their bone marrow with cells from wild-type mice or MPO-Tg mice. Despite having similarly high levels of cholesterol after maintenance on a high-fat, high-cholesterol diet, the MPO-Tg animals developed a 2-fold greater atherosclerotic area in the aorta than did mice transplanted with wild-type bone marrow (P=0.00003). CONCLUSIONS: Our observations indicate that expression of humanMPO in macrophages promotes atherosclerosis in hypercholesterolemicmice, raising the possibility that the enzyme might be a potential therapeutic target for preventing cardiovascular disease in humans.
Authors: Kim M O'Sullivan; Camden Y Lo; Shaun A Summers; Kirstin D Elgass; Paul J McMillan; Anthony Longano; Sharon L Ford; Poh-Yi Gan; Peter G Kerr; A Richard Kitching; Stephen R Holdsworth Journal: Kidney Int Date: 2015-07-15 Impact factor: 10.612
Authors: Stephen J Nicholls; W H Wilson Tang; Danielle Brennan; Marie-Luise Brennan; Shirley Mann; Steven E Nissen; Stanley L Hazen Journal: Clin Chem Date: 2011-09-22 Impact factor: 8.327
Authors: Uwe Jerke; Susanne Rolle; Bettina Purfürst; Friedrich C Luft; William M Nauseef; Ralph Kettritz Journal: J Biol Chem Date: 2013-03-26 Impact factor: 5.157
Authors: Andrea M Vincent; John M Hayes; Lisa L McLean; Anuradha Vivekanandan-Giri; Subramaniam Pennathur; Eva L Feldman Journal: Diabetes Date: 2009-07-10 Impact factor: 9.461
Authors: Robert S Rosenson; H Bryan Brewer; Benjamin J Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb Journal: Nat Rev Cardiol Date: 2015-09-01 Impact factor: 32.419